{
    "medicine_id": "f92e5368dbd36a2263b66e925640ec3a0cea7b67",
    "platform_id": "DB05226",
    "metadata": {
        "name": "Eucrisa 20 mg 1g Ointment",
        "composition": "20 mg 1g BTA9881",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of respiratory syncytial virus infections",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "BTA9881 will be used to stop replication of RSV in an infected patient with the aim of clearing the infection or reducing the clinical impact of the disease Respiratory syncytial virus RSV infects people of all ages but particularly infants causing similar symptoms to influenza In the northern hemisphere the RSV season usually starts in the fall and runs through the spring The virus is highly contagious infecting virtually all infants under the age of two and re infection is common For example approximately 50 percent of children will experience two RSV infections by the age of two",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}